3 Reasons to Avoid OCUL and 1 Stock to Buy Instead [Yahoo! Finance]
Ocular Therapeutix, Inc. (OCUL)
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ocutx.com
Company Research
Source: Yahoo! Finance
This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation. Is there a buying opportunity in Ocular Therapeutix, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it's free Why Do We Think Ocular Therapeutix Will Underperform? Despite the more favorable entry price, we don't have much confidence in Ocular Therapeutix. Here are three reasons there are better opportunities than OCUL and a stock we'd rather own. 1. Revenue Tumbling Downwards Long-term growth is the most important, but within healthcare, a stretched historical view may miss new innovations or demand cycles. Ocular Therapeutix's recent performance marks a sharp pivot from its five-year trend as its revenue has shown annualized declines of 5.7% over the last two years. Ocular Therapeutix Year-On-Year Revenue Growth 2. Shrinking Adjusted Operating Margin Adjusted operating margin is an important measure of p
Show less
Read more
Impact Snapshot
Event Time:
OCUL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCUL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCUL alerts
High impacting Ocular Therapeutix, Inc. news events
Weekly update
A roundup of the hottest topics
OCUL
News
- What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down [Yahoo! Finance]Yahoo! Finance
- Is It Time To Reassess Ocular Therapeutix (OCUL) After Its Recent Share Price Slide [Yahoo! Finance]Yahoo! Finance
- Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL) [Yahoo! Finance]Yahoo! Finance
- Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Ocular Therapeutix, Inc. (OCUL) Discusses Phase III SOL-1 Data Highlighting Transformative Durability in Wet AMD Transcript [Seeking Alpha]Seeking Alpha
OCUL
Earnings
- 11/4/25 - Beat
OCUL
Sec Filings
- 2/27/26 - Form 8-K
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- OCUL's page on the SEC website